Long-Term Lamivudine Treatment of Children with Chronic Hepatitis B: Durability of Therapeutic Responses and Safety
Lamivudine has been demonstrated safe and efficacious in the short term in a large cohort of children with chronic hepatitis B (CHB), but optimal duration of treatment has not been elucidated and limited data on the safety of long-term lamivudine administration have been reported. In addition, the d...
Autor principal: | |
---|---|
Outros Autores: | , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2016
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10400.17/2505 |
País: | Portugal |
Oai: | oai:repositorio.chlc.min-saude.pt:10400.17/2505 |